Methods: An integrative research review of the literature was conducted. Cochrane Library, CINAHL Plus Full Text, MEDLINE Complete, HealthSource: Nursing/Academic Edition, and PubMed were searched using the terms: “sodium bicarbonate” and “chronic kidney disease”. The search included results from 2012-2017. Inclusion criteria included sodium bicarbonate as treatment option for Chronic Kidney Disease. Literature was excluded for treatments including contrast induced nephropathy or care for End Stage Renal Disease. Data were synthesized to evaluate quality and the level of evidence, using an Evidence Hierarchy.
Results: Findings were synthesized for comparative analysis of results. Eighty-three articles were initially identified. Twenty-one articles met the study inclusion criteria. One Cochrane review and one systematic review were found and determined to be level one evidence. Three randomized control trials considered level two evidence. Three quasi-experimental studies and one expert consensus clinical guideline used were considered level four evidence. Two Integrated research reviews were considered level five. Five Literature reviews two editorial reviews and three study protocols were considered level six.
Conclusion: Research suggests that sodium bicarbonate is an effective treatment for slowing the progression of Chronic Kidney Disease. However, there is a need for the larger randomized control trials to determine when to initiate treatment, dosage, and the therapeutic level of serum sodium bicarbonate for optimal care of the Chronic Kidney Disease.
See more of: Invited Posters